Undercurrent CapitalbetaSign in
1 / 1
✕
NewsThe Defiant ·

Isomorphic Labs Raises $5 Billion for AI Drug Design

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again....

─ Neutral0 readers/hr

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.... Read the full story at The Defiant